Form 8-K - Current report:
SEC Accession No. 0000950170-24-133817
Filing Date
2024-12-06
Accepted
2024-12-05 20:53:09
Documents
15
Period of Report
2024-12-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20241204.htm   iXBRL 8-K 79647
2 EX-2.1 rkda-ex2_1.htm EX-2.1 839484
3 EX-99.1 rkda-ex99_1.htm EX-99.1 63490
4 GRAPHIC img192114479_0.jpg GRAPHIC 3553
5 GRAPHIC img192114479_1.jpg GRAPHIC 103938
  Complete submission text file 0000950170-24-133817.txt   1385818

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20241204.xsd EX-101.SCH 24852
17 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20241204_htm.xml XML 4670
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 241530336
SIC: 0100 Agricultural Production-Crops
(CF Office: 08 Industrial Applications and Services)